bremazocine has been researched along with Substance Withdrawal Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gambino, MC; Petrillo, P; Tavani, A | 1 |
| Amico, MC; Morrone, LA; Romanelli, L; Valeri, P | 1 |
2 other study(ies) available for bremazocine and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Bremazocine induces antinociception, but prevents opioid-induced constipation and catatonia in rats and precipitates withdrawal in morphine-dependent rats.
Topics: Analgesics; Animals; Benzomorphans; Catatonia; Constipation; Dose-Response Relationship, Drug; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Etorphine; Gastrointestinal Motility; Humans; Male; Morphinans; Morphine; Naloxone; Rats; Substance Withdrawal Syndrome; Substance-Related Disorders | 1984 |
Acute withdrawal after bremazocine and the interaction between mu- and kappa-opioid receptors in isolated gut tissues.
Topics: Animals; Benzomorphans; Guinea Pigs; In Vitro Techniques; Intestine, Small; Male; Morphine; Muscle Contraction; Naloxone; Rabbits; Receptors, Opioid, kappa; Receptors, Opioid, mu; Substance Withdrawal Syndrome | 1995 |